Studies on optimal dose and administration schedule of a hematopoietic stimulatory β-(1,4)-linked mannan

International Journal of Immunopharmacology

Volumn 18, Issue 2, 1996, Pages 113-126

  Egger, Stefan F ^a   Brown, Gregory S ^a   Kelsey, Linda S ^a   Yates, Kenneth M ^b   Rosenberg, Larry J ^b   Talmadge, James E ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b Carrington Laboratories Inc   (United States)

Author keywords

Acetylated mannan; Administration schedule; Biologic; Bone marrow; CFU C; Dose; Hematopoiesis; HPP CFC; Myelosuppression; Peripheral blood; Spleen

Indexed keywords

CARN 750; INTERLEUKIN 3; MANNAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD; BONE MARROW; BONE MARROW SUPPRESSION; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG DOSE; HEMATOPOIESIS; IRRADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029971934     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/0192-0561(95)00112-3     Document Type: Article

References (44)

1. Benacerraf, B. (1960). Influence of irradiation on resistance to infection. Bacteriol Rev., 24, 35-40.
2. 60Co gamma rays, vinblastine, and cytosine arabinoside. Exp. Hemat., 6, 2-8.
3. Bomford, R. & Moreno, C. (1977). Mechanism of the anti-tumour effect of glucans and fructosans: a comparison with C. parvum. Br. J. Cancer, 36, 41-48.
4. Broerse, J. J. & MacVittie, T. J. (1984). Response of Different Species to Total Body Irradiation. Martinus Nijhoff, Dordrecht.
5. Browder, W., Cohen, C., McNamee, R., Hoffmann, E. O. & Di Luzio, N. R. (1978). Suppression of hepatic metastases by immunization with glucan. In: Immune Modulation and Control of Neoplasia by Adjuvant Therapy (eds Chirigos, M. A.), pp. 207-219. Raven Press, New York.
6. Chen, Y.L. (1992). Effects of collagen and glucan on the healing of burn wounds in mice. Chung Hua Cheng Hsing Shao Shang Wai Ko Tsa Chih, 8, 54-56, 87-88.
7. Chinnah, A. D., Baig, M., Tizard, I. R. & Kemp, M. C. (1992). Antigen-dependent adjuvant activity of a polydispersed β-(1,4)-linked acetylated mannan (acemannan). Vaccine, 10, 551-558.
8. Deimann, W. & Fahimi, H. (1980). Induction of focal hemopoiesis in adult rat liver by glucan, a macrophage activator. Lab. Invest., 42, 217-224.
9. Hammond, C.W., Tompkins, M. & Miller, C.P. (1954). Studies on susceptibility to infection following ionizing radiation; time of onset and duration of endogenous bacteremias in mice. J. exp. Med., 99, 405-410.
10. Harris, C., Pierce, K., King, G., Yates, K. M., Hall, J. & Tizard, I. (1991). Efficacy of acemannan in treatment of canine and feline spontaneous neoplasms. Molec. Biother., 3, 207-213.
11. Hofer, M., Pospisil, M., Viklicka, S., Vacek, A., Pipalova, I. & Bartonickova, A. (1993). Hematopoietic recovery in repeatedly irradiated mice can be enhanced by a repeatedly administered combination of diclofenac and glucan. J. Leukoc. Biol., 53, 185-189.
12. Kahlon, J. B., Kemp, M. C., Yawei, N., Carpenter, R. H., Shannon, W. M. & McAnalley, B. H. (1991a). In vitro evaluation of the synergistic antiviral effects of acemannan in combination with azidothymidine and acyclovir. Molec. Biother., 3, 214-23.
13. Kahlon, J. B., Kemp, M. C., Carpenter, R. H., McAnalley, B. H., McDaniel, H. R. & Shannon, W. M. (1991b). Inhibition of AIDS virus replication in vitro. Molec. Biother., 3, 127-135.
14. King, G. K., Yates, K. M., Greenlee, P. G., Pierce, K. R., Ford, C. R., McAnalley, B. H. & Tizard, I. A. (1995). The effect of Acemannan immunostimulant, surgery and radiation on spontaneous canine and feline fibrosarcoma. J. Am. Anim. Hosp. Assoc., 31, 439-447.
15. Leibovici, J., Siegal, A., Kopel, S., Davidai, G. & Yavetz, H. (1989). Effects of cyclophosphamide and Levan treatment on bone marrow and peripheral blood cells in B16-F10 melanoma-bearing mice. Int. J. Immunopharmac., 11, 133-147.
16. Liskova, A., Wagnerova, J., Cervenakova, L., Kristofova, A. & Ferencik, M. (1990). The effect of soluble glucan derivates on spleen colony-forming units in sublethally irradiated mice. Folia Microbiol Praha, 35, 353-362.
17. MacVittie, T. J. (1979). Alterations induced in macrophage and granulocyte-macrophage colony forming cells by a single injection of mice with Corynebacterium parvum. J. Reticuloendothel. Soc., 26, 479-490.
18. Marshall, G. D., Gibbons, A. S. & Parnell, L. S. (1993). Human cytokines induced by acemannan. J. Allergy clin. Immun., 91, 295, (Abstract 619).
19. Ohno, N., Saito, K., Nemoto, J., Kaneko, S., Adachi, Y., Nishijima, M., Miyazaki, T. & Tadomae, T. (1993). Immunopharmacological characterization of a highly branched fungal (1→3)-β-D-glucan, OL-2, isolated from Omphalia lapidescens. Biol. Pharm. Bull., 16, 414-419.
20. Olstad, R. & Seljelid, R. (1980). The cellular reaction in normal and tumor-bearing mice following intraperitoneal glucan injection. Acta Path. Microbiol. Scand. Sect. C, 88, 97-101.
21. Patchen, M. L., DiLuzio, N. R., Jacques, P. & MacVittie, T. J. (1984). Soluble polyglycans enhance recovery from cobalt-60-induced hemopoietic injury. J. Biol. Resp. Mod., 3, 627-633.
22. Patchen, M.L. & Lotzova, E. (1980). Modulation of murine hemopoiesis by glucan. Exp. Hemat., 8, 409-422.
23. Patchen, M. L. & Lotzova, E. (1981). The role of macrophages and T-lymphocytes in glucan-mediated alteration of murine hemopoiesis. Biomedicine, 34, 71-77.
24. Patchen, M. L. & MacVittie, T. J. (1983a). Dose-dependent responses of murine pluripotent stem cells and myeloid and erythroid progenitor cells following administration of the immunomodulating agent glucan. Immunopharmacology, 5, 303-313.
25. Patchen, M. L. & MacVittie, T. J. (1983b). Temporal response of murine pluripotent stem cells and myeloid and erythroid progenitor cells to low-dose glucan treatment. Acta Haemat., 70, 281-288.
26. Patchen, M. L. & MacVittie, T. J. (1985). Stimulated hemopoiesis and enhanced survival following glucan treatment in sublethally and lethally irradiated mice. Int. J. Immunopharmac., 7, 923-932.
27. Patchen, M. L. & MacVittie T. J. (1986a). Comparative effects of soluble and particulate glucans on survival in irradiated mice. J. Biol. Resp. Mod., 5, 45-60.
28. Patchen, M. L. & MacVittie, T. J. (1986b). Hemopoietic effects of intravenous soluble glucan administration. J. Immunopharmac., 8, 407-425.
29. Peng, S. Y., Norman, J., Curtin, G., Corrier, D., McDaniel, H. R. & Busbee, D. (1991). Decreased mortality of Norman murine sarcoma in mice treated with the immunomodulator, acemannan™. Molec. Biother., 3, 79-87.
30. Petros, W. P. & Peters, W. P. (1993). Cost implications of haematopoietic growth factors in the BMT setting. Bone Marrow Transplant., 11 (Suppl. 2), 36-38.
31. Pretus, H. A., Ensley, H. E., McNamee, R. B., Jones, E. L., Browder, I. W. & Williams, D. L. (1991). Isolation, physicochemical characterization and preclinical efficacy evaluation of soluble scleroglucan. J. Pharmac. exp. Ther., 257, 500-510.
32. Ramamoorthy, L., Kemp, M. C. & Tizard, I. R. (1993). Effects of acemannan on the production of cytokine in a macrophage cell line RAW264.7. Presented at the Joint Meeting of the European Tissue Repair Society and Wound Healing Society, Amsterdam, The Netherlands (Abstract 16).
33. Riggi, S. & DiLuzio, N. (1961). Identification of a reticuloendothelial stimulating agent in zymosan. Am. J. Physiol., 200, 297-300.
34. Ritchie, B. W., Niagro, F. D., Latimer, K. S., Prtichard, N., Greenlacre, C., Campagnoli, R. P. & Lukert, P. D. (1994). Antibody response and local reactions to adjuvant avian polyomavirus vaccines in psittacine birds. J. Assoc. Avian. Vet., 8, 21-26.
35. Robbins, S. & Angell, M. (1976). Basic Pathology. W. B. Saunders, Philadelphia.
36. Scott, M. (1974). Cornebacterium parvum as a therapeutic antitumor agent in mice. 1. Systemic effects of intravenous infection. J. natn. Cancer Inst., 53, 855-860.
37. Seljelid, R. (1986). A water-soluble aminated β-1-3D-glucan derivative causes regression of solid tumors in mice. Biosci. Rep., 6, 845-851.
38. Suzuki, S. Suzuki, M., Matsumoto, T. & Okawa, Y. (1970). Growth inhibition of sarcoma-180 solid tumor by the cells of regional lymph node and spleen of mice administered with yeast polysaccharides. Gann, 62, 343-352
39. Tizard, I. R., Busbee, D., Maxwell, B. & Kemp, M. C. (1994). Effects of acemannan, a complex carbohydrate, on wound healing in young and aged rats. Wounds, 6, 201-209.
40. Tizard, I. R., Carpenter, R. H., McAnalley, B. H. & Kemp, M. C. (1989). The biological activities of mannans and related complex carbohydrates. Molec. Biother., 1, 290-296.
41. Williams, W., Beutler, E., Erslev, A. & Rundles, W. (1972). Hematology. McGraw-Hill, New York.
42. Williams, D. L., Sherwood, E. R., Browder, I. W., McNamee, R. B., Jones, E. L. & Luzio, N. R. D. (1988). Pre-clinical safety evaluation of soluble glucan. Int. J. Immunopharmac., 10, 405-414.
43. Wolk, M. & Dannon, D. (1985). Promotion of wound healing by yeast glucan evaluated on single animals. Med. Biol., 63, 73-80.
44. Womble, D. & Helderman, J. H. (1988). Enhancement of allo-responsiveness of human lymphocytes by acemannan (Carrisyn™). Int. J. Immunopharmac., 10, 967-974.